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Abstract
The Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) provided states with an
optional Medicaid eligibility category for uninsured women with breast and/or cervical cancers. The
BCCPTA is the first and only such effort to use a population-based public health screening program,
the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide a pathway to
publicly funded health insurance for otherwise uninsured low-income women. Georgia was one of the
first states to adopt the BCCPTA and was one of only twelve states that provided Medicaid eligibility to
women screened by non-NBCCEDP providers. We use 2003 Georgia Medicaid claims and enrollment
data to investigate the scope of the state’s BCCPTA enrollment and enrollees’ costs as well as
demographic characteristics of breast and cervical cancer patients in Georgia’s BCCPTA and other
Medicaid eligibility categories. Georgia’s Medicaid coverage of women with breast and/or cervical
cancer under BCCPTA accounted for over one-third of all women with these cancers covered by the
state in 2003 alone. Those newly eligible under BCCPTA were more likely to have breast, as opposed
to cervical, cancer and to be older than those women with breast/cervical cancers enrolled in Georgia
Medicaid due to low-income, pregnancy or disability status. Georgia’s Medicaid program spent over
$29 million on BCCPTA enrollees in 2003 at a cost of over $12,000 per enrollee. BCCPTA enrollee
costs were more similar to those for disabled women with these cancers, about $19,500, than to
costs for low-income/pregnant women which equaled about $7,500. By expanding Medicaid
coverage, BCCPTA can potentially bring women in at earlier stages of their cancer and provide needed
coverage/treatment. Future research should examine the potential effect of BCCPTA on reduced
morbidity and mortality among these low-income women.

The Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) in Georgia:
Women Covered and Medicaid Costs in 2003
On October 24, 2000, President Clinton
signed the Breast and Cervical Cancer
Prevention and Treatment Act (BCCPTA). The
BCCPTA, enacted as Public Law 106-354,
gave states the ability to establish a new
optional Medicaid eligibility category for
uninsured women under 65 who had been
screened under the National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP) and found to need treatment
either for breast or cervical cancer or for a
precancerous cervical condition. The
NBCCEDP serves the uninsured with
incomes below 250% of the federal poverty
level (FPL). The first and only such effort to
use a population-based public health
screening program (NBCCEDP), BCCPTA was
established as an effort to reduce the
decades-old “treatment gap” for low-income
women with no medical insurance by
providing a pathway to publicly funded
health insurance (Medicaid).
The BCCPTA has generated significant
interest as a policy approach for addressing

the challenges of the uninsured facing
serious illness. Within a year of its passage,
a majority of states had adopted the
BCCPTA. Georgia adopted the BCCPTA
pursuant to broad statutory authority by the
Medicaid agency and began enrolling
women in its BCCPTA program, the Women’s
Health Medicaid Program (WHMP), on July
1, 2001. From implementation through June
2006, BCCPTA enrolled approximately
4,800 women (Georgia Department of
Community Health, 2006). Although BCCPTA
mandated that women be screened by the
NBCCEDP, states had options to also extend
eligibility to women screened by nonNBCCEDP providers. Georgia is one of 12
states that selected this more expansive
screening option. In 2005, only 25% of
BCCPTA women were screened in health
departments through Georgia’s NBCCEDP
screening program (known as “Breast Test
and More”); the majority (75%) was
screened by private providers (Department
of Community Health, 2006).
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Another distinction of BCCPTA from other
Medicaid eligibility categories is that women
are eligible for Medicaid only as long as they
are “in treatment” for their cancers, but they
can utilize any Medicaid covered service
while eligible. If a BCCPTA woman is no
longer in treatment at the time of
recertification and if she is not eligible for
Medicaid under other eligibility categories,
she is disenrolled and usually referred back
to her screening provider for follow-up care.
The definition of “in treatment” is not
explicit, however, and states differ in the
timing and types of recertification required
to confirm active cancer treatment. In order
for BCCPTA women to get recertified in
Georgia in 2003, they simply responded to
Georgia’s Medicaid program by letter every
six months indicating that they were still in
active treatment. Since this time, Georgia’s
Medicaid officials have considered a more
formal process, whereby Breast Test and
More staff could assist with the
recertification process. Given the unique
collaboration of states’ screening programs
and Medicaid agencies in determining
eligibility, many NBCCEDP case managers
assist women before, during, and after their
treatment has ended. Although assisting
with redetermination has become a logical
role for these case managers, it is unclear
what this change will mean for the
percentage of women retaining coverage
under BCCPTA eligibility.
BCCPTA Study
Despite successful enrollment, little is
known about how states’ adoption and
implementation of the BCCPTA impacts lowincome, uninsured women with breast and
cervical cancer, nor how much it expands
pre-existing Medicaid coverage of women
with cancer. In 2004, Emory University
received funding from the American Cancer
Society (ACS) to examine the impact of
BCCPTA in Georgia. This study uses
quantitative
data
from
Medicaid
enrollment/claims
and
Georgia’s
Comprehensive Cancer Registry (GCCR) data
to assess if: 1) implementation of BCCPTA

shortened the length of time between initial
diagnosis and eventual enrollment into
Medicaid; 2) women enrolling in Medicaid
do so at earlier stages of cancer post
BCCPTA and hence, with greater treatment
options; and 3) significant variation (e.g.,
urban/rural) in treatment patterns exist. As
a first step, we use 2003 Medicaid claims
and enrollment data to ask:
• What is the scope of BCCPTA enrollment
and costs in Georgia’s Medicaid program?
• How does this fit into Georgia’s overall
coverage of women with breast or cervical
cancer?
• What are the demographic characteristics
of women enrolled in the BCCPTA
program, or in other Medicaid programs?
Assembling the claims/enrollment data is
necessary
to
determine
the
procedure/diagnostic codes to identify
women in Medicaid with evidence of breast
and cervical cancers for our larger study.
The resulting descriptive data are presented
here to highlight the role that BCCPTA is
playing in Georgia’s Medicaid program.
BACKGROUND LITERATURE
Women facing critical health challenges
are in need of health insurance. If early
symptoms or chronic diseases are not
medically managed, uninsured women are
more likely to experience poorer medical
outcomes or to be diagnosed at later stages
of life-threatening diseases such as cancer;
in turn, they experience a greater risk of
death from breast cancer (ACP, 2000; CDC,
1998). The BCCPTA was developed to
reduce both morbidity and mortality among
women with such conditions.
Even prior to BCCPTA, Medicaid served
as an important safety net for women with
chronic health conditions and yet, there are
relatively few studies specific to Medicaid
enrollees with cancer (CDC, 1998). One
earlier study showed that the Medicaid
insured presented with more advanced
disease. Further, both Medicaid enrolled
and uninsured women diagnosed with local
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or regional stage disease had worse survival
than privately-insured women, although
there was no significant difference among
women with distant metastases (Ayanian,
Kohler, Abe, and Epstein, 1993). Another
study found older, black women of lower
socio-economic status treated in public
hospitals (likely eligible for Medicaid) were
more likely to have late stage breast or
cervical cancer than younger, white, higher
social class women treated in non-public
hospitals (Mandleblatt, Andrews, Kerner,
Zauber, and Burnett, 1991).
A study that linked Medicaid enrollment
and Detroit cancer registry data found that
Medicaid-insured women were more likely to
have late-stage diagnosis, less likely to
receive radiation if they had breast
conserving surgery (BCS) and more likely to
receive no surgery than other insured
women (Bradley, Given, and Roberts, 2002).
This linkage also provided new insight on
racial disparities. Before controlling for
Medicaid and area poverty, AfricanAmerican women had a higher likelihood of
each unfavorable outcome but after
controlling, African-American women only
differed in treatment choice. They were less
likely to have any surgery and if they did, it
was more likely to be BCS (Bradley, 2002).
Thus low socioeconomic status, as
evidenced by Medicaid enrollment, was a
better predictor than race of disease stage
at diagnosis.
Another study used Medicaid claims
data to identify incident cases in Ohio’s
Medicaid population with registry data as
the “gold standard” (Koroukian, Cooper, and
Rim, 2003). The overall sensitivity was
68.7%, but varied by sub-group and was as
high as 78% for those enrolled all year. A
linkage of Medicaid and California registry
data found that of the 14,305 matched
cases, 70% were not enrolled in Medi-Cal
(California’s Medicaid program) either prior
to or during the month of diagnosis (Perkins,
Write, Allen, Samuels, and Romano, 2001).
These authors concluded that despite
difficulties in linking, such data can be used
to assess access to care and cancer

outcomes in this large, understudied and
vulnerable population.
DATA AND METHODS
While BCCPTA women can be identified
based on eligibility codes, other women with
breast or cervical cancer in Medicaid
programs can only be identified using
diagnosis/procedure codes found in claims.
We use calendar year 2003 claims to
identify all women with evidence of these
cancers. We compiled lists of diagnosis and
procedure codes (and NDC chemotherapy
codes) from publications, consultation with
Georgia Medicaid staff, and with our team’s
clinical oncologist. We cast a broad net to
find women with breast or cervical cancers
in Georgia Medicaid but were conservative
when using procedure codes without a
cancer diagnosis (during the year) since this
could lead to over-identification of cancer
cases. The list of codes employed to derive
the samples is shown in Table 1.
We identified all unique women with at
least one claim with any of these codes from
inpatient, outpatient, drug, and long-term
care claims. From this pool of women, we
excluded: 1) women over 65; 2) women
dually enrolled in Medicare; and 3) women
in a nursing home during the year. These
exclusions were necessary since not all
‘crossover’ claims - those involving both
Medicare and Medicaid payments - nor longterm care claims include all diagnostic,
procedure, and payment detail. By making
these exclusions, we identified a group of
relatively younger women insured largely by
Medicaid who were more comparable with
those eligible for Medicaid through BCCPTA.
We then grouped women by the eligibility
category on their first (cancer-related) claim
during the year: 1) BCCPTA; 2) welfare or
pregnancy-related; and 3) disabled women.
Women with dependent children could
qualify for Georgia Medicaid under welfarerelated criteria at approximately 33% of the
Federal Poverty Level (FPL); FPL for a family
of three equaled $15,260 in 2003 (CMS,
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Table 1
ICD-9 Breast and Cervix Cancer Diagnosis Codes, NDC Chemotherapy Codes, and CPT Breast and
Cervix Procedure Codes
Codes
Breast Cancer Diagnosis ICD-9 Codes

233.0,174.0-174.9,238.3,239.3

Cervix Cancer Diagnosis ICD-9 Codes

622.1,233.1,180.0-180.9

Chemotherapy NDC Codes

54569-3765-00, 54569-8602-00, 00555-044609, 00555-0446-63, 00555-0446-05, 005550904-01, 00555-0904-14, 00555-0904-05,
51552-0838-02, 63370-0251-10, 63370-025115, 63370-0251-25, 63370-0251-35, 001725656-49, 00172-5656-58, 00172-5656-70,
00172-5656-80, 00172-5657-46, 00172-565760, 00172-5657-70, 00172-5657-80, 387790341-03, 38779-0341-01, 38779-0341-04,
38779-0341-05, 62991-1151-02, 62991-115101, 00378-0144-91, 00378-0274-93, 003780274-01, 54868-3004-02, 54868-3004-01,
00054-4831-21, 00054-8831-25, 00054-483126, 00054-4834-13, 00054-4834-22, 000548834-25, 49452-7571-05, 49452-7571-01,
49452-7571-02, 49452-7571-06, 49452-757103, 00093-0784-06, 00093-0784-86, 000930782-56, 00093-0782-01

Breast Procedure CPT Codes

19160; 19162; 19180; 19182; 19200; 19220;
19240

Cervix Procedure CPT Codes

57520; 57522

2003). Pregnant women under 235% of the
FPL would have qualified for Georgia
Medicaid, and a woman with a disabling
condition and on Supplemental Security
Income (SSI), approximately 74% of the FPL,
would have qualified in 2003 (VCU, 2006).
RESULTS
The data in Table 2 show that, based on
administrative files, a total of 2,379 women
were enrolled in Georgia’s BCCPTA program
at some point during 2003. These women
were almost evenly split across the three
non-teenage categories; roughly one-third
were in each age group under 65. Based on
those with race/ethnic data (91% of total),
the women enrolled in BCCPTA in 2003
were predominantly white non-Hispanic

(54%) with 32% categorized as non-Hispanic
Black, 2% as Hispanic, and 2% as “other”
ethnic groups.
Given the significant
proportion of missing race data, it is likely
that
the
percent
Hispanic
is
underrepresented. Survey data on families
with children in Medicaid in 2003 indicate
5% of the higher income, and 10% of the
lower income families, were Hispanic
(Ketsche, 2007). BCCPTA women however,
accounted for only 36% of the total 4,573
identified by claims/codes (1,655 BCCPTA,
1,887 welfare/pregnancy related and 1,031
disabled). Based on the costs of those ever
enrolled in BCCPTA, Medicaid spent $29
million or about $12,400 per woman. The
$27 million spent on BCCPTA enrollees with
breast/cervical cancer claims represents
44% of costs for women ($61.6 million)
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Table 2
Age, Race, Cost Breakdown for Women Ever Enrolled in BCCPTA, Women with Claims for Breast or Cervical
Cancers and Eligible for BCCPTA on First Claim, Georgia Medicaid 2003
BCCPTA w/
Women with Breast
Women with Cervical
Breast/Cervical
All BCCPTA-Ever
Cancer Claims and
Cancer Claims and
Cancer Claims and
Enrolled in Year
BCCPTA Eligible at First
BCCPTA Eligible at
BCCPTA Eligible at
Claim
First Claim
First Claim
N=2,379

%

Unduplicated
N=1,655
Duplicated
N=1,688

%

N=1,093

%

N=595

%

33
773
773
800

1%
32%
32%
34%

23
335
631
666

1%
20%
38%
40%

0
57
451
585

0%
5%
41%
54%

23
284
194
94

4%
48%
33%
16%

1284
762
59
49
225

54%
32%
2%
2%
9%

809
586
33
39
188

49%
35%
2%
2%
11%

468
439
16
30
140

43%
40%
1%
3%
13%

355
158
18
9
55

60%
27%
3%
2%
9%

$29,409,475
$5,469,035
$20,865,546
$3,074,894

100%
19%
71%
10%

$27,166,949
$5,062,505
$19,346,937
$2,757,508

100%
19%
71%
10%

$22,171,588
$3,439,421
$16,296,716
$2,435,452

100%
16%
74%
11%

$ 5,857,984
$1,790,438
$3,682,447
$385,099

100%
31%
63%
7%

$12,362
$2,299
$8,771
$1,293

100%
19%
71%
10%

$16,415
$3,059
$11,690
$1,666

100%
19%
71%
10%

$20,285
$3,147
$14,910
$2,228

100%
16%
74%
11%

$9,845
$3,009
$6,189
$647

100%
31%
63%
7%

AGE
<20
20-34
35-49
50-64
RACE
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Missing
COSTS
Total
Inpatient Services
Outpatient Services
Drug
COSTS PER
ENROLLEE
Total
Inpatient Services
Outpatient Services
Drug

identified by claims/codes. Both the BCCPTA
and disabled eligibility category of women
have costs that represent more of the total
than they do of women covered because
their per-person costs are significantly
higher than those of low-income pregnant
women. Most of the latter group are
experiencing cervical cancers and at a much
lower cost per case.
For BCCPTA and other groups of
enrollees outpatient services (e.g. physician
and other ambulatory services such as
laboratory, screening, etc) are more
expensive in total and per person due
largely to their greater volume. While
inpatient
services
(e.g.
hospital
accommodations, surgical services, etc) are
more costly per event there is a lower rate of
usage per person.

BCCPTA Eligible Women
We identified 1,655 unduplicated women
with breast or cervical cancers with BCCPTA
eligibility on their first cancer claim. The
difference between this and the 2,379 ever
enrolled in BCCPTA during 2003 is
comprised of: 1) 29 women who did not
have BCCPTA on their first claim, but who
were enrolled during the year, and 2) 695
women in BCCPTA who either did not have a
claim or had one outside of our identified
diagnosis or procedure codes. Some of the
695 may have had precancerous cervical
conditions (which qualify for BCCPTA). While
we found such codes among their leading
diagnoses, by and large, the leading
diagnoses were not cancer-related. These
695 women could also have had disease in
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remission, but still considered “under
treatment;” the great majority of them
(almost 75%) either had no claim during the
year (15%) or had at least one ‘case
management’ claim/procedure (59%) listed
by Georgia BCCPTA.
The split between breast and cervical
cancer using the data based on claims is
shown in Columns 2-3 in Table 2. Among the
1,688 duplicated (33 had claims for both)
BCCPTA women with either cancer, breast
cases accounted for 65%. Total payments
for BCCPTA women with claims for breast or
cervical cancer were $27 million, equal to
$16,415 per woman. For breast cancer
cases, total payments were $22 million,
equal to $20,285 per woman. For cervical
cancer cases, total payments were $5.8
million, equal to $9,845 per woman.
Welfare and Pregnancy Related Eligible
Women
The Georgia Medicaid program serves
many women with these and other cancers
outside of BCCPTA. As shown in Table 3,
almost 1,900 women with either cancer and
in either welfare or pregnancy-related
eligibility categories received treatment in
2003. (Data on the age/racial distributions
should be compared with that in Columns 23 in Table 2 which are also derived based
on claims/codes). These data indicate that
women with breast or cervical cancers in
these eligibility groups are far more likely to
be under age 35 (78% versus 33%) than
BCCPTA enrollees and indeed, more likely to
be teenagers (19% versus 1%). Even
accounting for missing race, they are more
likely to be non-Hispanic Blacks than are
BCCPTA enrollees.
In contrast to BCCPTA, cervical cancer
was far more common among Medicaid
patients in the welfare or pregnancy
categories (77% of these 1,895 duplicated
cases). The costs per case among these
younger women are lower at $7,548 overall
(total payments were $14 million). For those
with breast cancer, the average cost per
case was $12,200 (total payments were $5
million) while costs for cervical cancer cases

averaged $6,234, with total payments of $9
million.
Disabled Women
Georgia and other states’ Medicaid
programs have historically served the lowincome with disabling conditions. As shown
in Table 4, a little over 1,000 women with
evidence of breast or cervical cancers and
disabled by these or other conditions were
served in 2003. As among BCCPTA women,
the cases are predominately breast cancer
(72%), and the costs per woman are similar
at almost $20,000. There are almost 300
disabled women with evidence of cervical
cancer, and these cases are just as costly as
for BCCPTA women at $19,718. Women in
this eligibility category are likely to be older
than either BCCPTA women or women in the
welfare and pregnancy related categories
with approximately 59% between the ages
of 50 and 64.
CONCLUSIONS AND IMPLICATIONS
Prior to BCCPTA, many uninsured women
with breast or cervical cancer qualified for
Medicaid only when they were at late stages
of disease and perhaps disabled by it
(Ayanian et al., 1993). The time between
diagnosis and treatment was likely long for
uninsured women who could not either
afford treatment or find doctors willing to
provide charity care. The BCCPTA created a
potentially new and quicker pathway into
Medicaid. The data shown here indicate that
BCCPTA women with breast cancer are more
like the Medicaid disabled than those
eligible through other avenues, in terms of
age and costs, but are still younger and
somewhat less expensive to serve. BCCPTA
women with cervical cancers are certainly
younger than the disabled women, and they
have markedly lower costs. This may reflect
detection/treatment at earlier stages of
disease or a lack of co-morbidities among
BCCPTA women compared with those the
disabled possess.
When BCCPTA was created, there was
little information for state policy makers
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Table 3
Age, Race, Cost Breakdown for Women with Claims for Breast or Cervical Cancers and Enrolled in
Welfare or Pregnancy-Related Category on First Claim, Georgia Medicaid 2003
Women with Breast
Women with Breast
Women with Cervical
or Cervical Cancer
Cancer Claims and
Cancer Claims and
Claims and Welfare
Welfare or PregnancyWelfare or Pregnancyor PregnancyRelated Eligibility at First Related Eligibility at First
Related Eligibility at
Claim
Claim
First Claim
Unduplicated
N=1887
Duplicated
N=1,895

%

N=440

%

N=1455

%

<20
20-34
35-49
50-64

352
1118
363
54

19%
59%
19%
3%

47
138
206
49

11%
31%
47%
11%

305
982
163
5

21%
67%
11%
0%

Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Missing

811
1051
3
11
11

43%
56%
0%
1%
1%

147
280
1
4
8

33%
64%
0%
1%
2%

669
774
2
7
3

46%
53%
0%
0%
0%

$14,243,272
$3,399,623
$9,414,445
$1,429,204

100%
24%
66%
10%

$5,368,003
$1,271,492
$3,492,421
$604,089

100%
24%
65%
11%

$9,070,747
$2,225,033
$6,013,085
$832,629

100%
25%
66%
9%

$7,548
$1,802
$4,989
$757

100%
24%
66%
10%

$12,200
$2,890
$7,937
$1,373

100%
24%
65%
11%

$6,234
$1,529
$4,133
$572

100%
25%
66%
9%

AGE

RACE

COSTS
Total
Inpatient Services
Outpatient Services
Drug
COSTS PER ENROLLEE
Total
Inpatient Services
Outpatient Services
Drug

regarding the costs that Medicaid would
face since data on the costs of cancer
treatment are often limited. Many states
made estimates of anticipated BCCPTA
costs but these have not been made
available to researchers. In a study based
on the Medical Expenditure Panel Survey
(MEPS), Medicaid insured (age <65) had
expenses close (93%) to those of the
privately insured, but both had much higher
expenses than the uninsured (Thorpe and
Howard, 2003). The uninsured were also
found to have lower provider encounters
and fewer hospital admissions, perhaps
indicative of less cancer care. On an
annualized basis, the expenses for the
Medicaid insured were $15,610 (Thorpe
and Howard, 2003), lower but still quite

consistent with the dollar amounts reported
here for Georgia Medicaid women with
breast cancer.
While BCCPTA women accounted for over
one-third of the women under age 65 served
by Georgia’s Medicaid program in 2003 (the
second year of BCCPTA), it is important to
note the role Medicaid coverage plays
independent of BCCPTA. Georgia Medicaid
insured almost 2,000 younger women with
breast and especially, cervical cancers
among women in their pregnancy or welfare
eligibility groups. That these young women
end up using Medicaid for these diagnoses
relates in part to screening for cervical
cancer at younger ages than other cancers
and that many women who are single heads
of households and/or young married
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Table 4:
Age, Race, Cost Breakdown for Women with Claims for Breast or Cervical Cancers and Enrolled in Disability
Category on First Claim, Georgia Medicaid 2003
Women with Cervical
Women with Breast or Cervical
Women with Breast Cancer
Cancer Claims and
Cancer Claims and Disability
Claims and Disability
Disability Eligibility at First
Eligibility at First Claim
Eligibility at First Claim
Claim
Unduplicated N=1031
Duplicated
N=1,042

%

N = 749

%

N=293

%

<20
20-34
35-49
50-64

13
98
316
604

1%
10%
31%
59%

3
26
215
505

0%
3%
29%
67%

10
73
106
104

3%
25%
36%
35%

Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Missing

356
497
7
9
162

35%
48%
1%
1%
16%

251
361
6
6
125

34%
48%
1%
1%
17%

109
142
1
3
38

37%
48%
0%
1%
13%

$20,210,958
$5,540,801
$11,054,919
$3,615,238

100%
27%
55%
18%

$14,862,105
$3,739,745
$8,392,379
$2,729,981

100%
25%
56%
18%

$5,777,233
$1,918,383
$2,884,074
$974,776

100%
33%
50%
17%

$19,603
$5,374
$10,723
$3,507

100%
27%
55%
18%

$19,843
$4,993
$11,205
$3,645

100%
25%
56%
18%

$19,718
$6,547
$9,843
$3,327

100%
33%
50%
17%

AGE

RACE

COSTS
Total
Inpatient Services
Outpatient Services
Drug
COSTS PER ENROLLEE
Total
Inpatient Services
Outpatient Services
Drug

mothers are likely to lack private insurance
coverage (Guyer, Broaddus, and Dude,
2001). Given high cure rates for cervical
cancer with early detection/treatment, both
traditional Medicaid eligibility and the
expansion through BCCPTA can serve as a
critical safety net and perhaps help reduce
morbidity and mortality related to this
preventable cancer.
The NBCCEDP has just been reauthorized
through fiscal year 2011. While funding has
increased, it still falls far below that needed
to cover all uninsured women for free or
subsidized screens. If uninsured women
still get screened and if screening leads to a
cancer diagnosis, BCCPTA can provide
needed coverage/treatment.
Georgia’s
experience shows that 75% of the otherwise
BCCPTA-eligible women received screening
privately. If this experience can be
generalized to other states, it is important
that they consider expanding BCCPTA to

women screened by any provider. Future
research should examine the role of BCCPTA
in bringing women into Medicaid at earlier
stages and potentially, reducing morbidity
and mortality as it was intended to do.
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